Eli Lilly halts two clinical trials of an experimental Alzheimer's treatment
Eli Lilly halted two late-stage clinical trials of an experimental Alzheimer's treatment on Tuesday, representing a setback to one leading theory on treating the degenerative disease and a new blow to Lilly's business prospects.
Findings from mouse studies suggest that a healthy diet might halt the progression of and even reverse the effects of Alzheimer's disease and memory loss.